1. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
- Author
-
Flach, Anne-Christine, Litke, Tanja, Strauss, Judith, Haberl, Michael, Cordero Gómez, César, Reindl, Markus, Saiz, Albert, Fehling, Hans-Jörg, Wienands, Jürgen, Odoardi, Francesca, Lühder, Fred, and Flügel, Alexander
- Subjects
T cells ,AUTOANTIBODIES ,GENETICS of autoimmune diseases ,GENETICS of multiple sclerosis ,CNS demyelinating autoimmune diseases ,PHYSIOLOGY - Abstract
Multiple sclerosis (MS) is caused by T cells that are reactive for brain antigens. In experimental autoimmune encephalomyelitis, the animal model for MS, myelin-reactive T cells initiate the autoimmune process when entering the nervous tissue and become reactivated upon local encounter of their cognate CNS antigen. Thereby, the strength of the T-cellular reactivation process within the CNS tissue is crucial for the manifestation and the severity of the clinical disease. Recently, B cells were found to participate in the pathogenesis of CNS autoimmunity, with several diverse underlying mechanisms being under discussion.We here report that B cells play an important role in promoting the initiation process of CNS autoimmunity. Myelin-specific antibodies produced by autoreactive B cells after activation in the periphery diffused into the CNS together with the first invading pathogenic T cells. The antibodies accumulated in resident antigen-presenting phagocytes and significantly enhanced the activation of the incoming effector T cells. The ensuing strong blood-brain barrier disruption and immune cell recruitment resulted in rapid manifestation of clinical disease. Therefore, myelin oligodendrocyte glycoprotein (MOG)-specific autoantibodies can initiate disease bouts by cooperating with the autoreactive T cells in helping them to recognize their autoantigen and become efficiently reactivated within the immune-deprived nervous tissue. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF